Antibody Drug Conjugate Market
Antibody Drug Conjugate Market Size, Share, Statistics & Trends Analysis Report By Product (Kadcyla, Enhertu, Adcetris, Padcev, Trodelvy, Polivy), By Linker Type (Non-Cleavable, Cleavable), By Target (HER2, CD22, CD30), By Payload Type (MMAE/auristatin, calicheamicin, Maytansinoids), By Linker Technology Type (VC, Sulfo-SPDB, VA, Hydrazone), By Disease Type (Breast Cancer, Blood Cancer, Lung Cancer, Ovarian Cancer), By End-User (Hospitals and Specialty Cancer Centers, Biotechnology and Pharmaceutical Companies) Other Based On Region, And Segment Forecasts, 2025 – 2031
- Product Id: BMRC 3153
- Pages: 300
- Publish Date: Jan-2025
- Category: Pharmaceutical
Fill Details
Verify Email
Check your inbox for Sample + Methodology
Note: For delivery of sample pages you must have a Domain Specific EmailID, normally your business email address complies. Generic Email IDs such as AOL, Hotmail, Yahoo, Gmail, MSNetc are not accepted
Segments
Global Antibody Drug Conjugate Market Segmentation:
By Product:
- Kadcyla
- Enhertu
- Adcetris
- Padcev
- Trodelvy
- Polivy
- Others
By Linker Type:
- Non-Cleavable
- Cleavable
By Target:
- HER2
- CD22
- CD30
- Others
By Payload Type:
- MMAE/auristatin
- calicheamicin
- Maytansinoids
- Others
By Linker Technology Type:
- VC
- Sulfo-SPDB
- VA
- Hydrazone
- Others
By Disease Type:
- Breast Cancer
- Blood Cancer (e.g., Hodgkin lymphoma, non-Hodgkin lymphoma)
- Lung Cancer
- Ovarian Cancer
- Other
By End-User:
- Hospitals and Specialty Cancer Centers
- Biotechnology and Pharmaceutical Companies
- Other
Regions and Country
North America
- U.S.
- Canada
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Sweden
- Netherlands
- Turkey
- Switzerland
- Belgium
- Rest of Europe
Asia-Pacific
- South Korea
- Japan
- China
- India
- Australia
- Philippines
- Singapore
- Malaysia
- Thailand
- Indonesia
- Rest of APAC
Latin America
- Mexico
- Colombia
- Brazil
- Argentina
- Peru
- Rest of South America
Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- South Africa
- Rest of MEA
Key Players
Key Players
- Roche (Genentech)
- Seagen Inc.
- Amgen Inc.
- Bristol-Myers Squibb
- Pfizer Inc.
- Merck & Co.
- Eli Lilly and Company
- AstraZeneca Plc
- Sanofi S.A.
- Bayer AG
- Gilead Sciences, Inc.
- Boehringer Ingelheim GmbH
- Takeda Pharmaceutical Company
- Astellas Pharma Inc.
- Macrogenics, Inc.
- Genmab A/S
- Mersana Therapeutics
- ImmunoGen, Inc.
- AstraZeneca and Daiichi Sankyo Company
- AbbVie Inc.
- BiomX, Inc.
- Lonza Group
- Zymeworks Inc.
- ADC Therapeutics SA
- BioAtla, Inc.
- Creative Biolabs
- Abzena Ltd.
- CytomX Therapeutics, Inc.
- Innate Pharma SA
- Oxford BioTherapeutics
- WuXi Biologics
- Almac Group
+44-1173181773
sales@brandessenceresearch.com
We are always looking to hire talented individuals with equal and extraordinary proportions of industry expertise, problem solving ability and inclination interested? please email us hr@brandessenceresearch.com
JOIN USFIND ASSISTANCE
LONDON OFFICE
BrandEssence® Market Research and Consulting Pvt ltd.
124, City Road, London EC1V 2NX
FOLLOW US
© Copyright 2025-26 BrandEssence® Market Research and Consulting Pvt ltd. All Rights Reserved | Designed by BrandEssence®
